That’s a wrap for #ADC2025 Some wonderful and brave videos from Type1Screen and ENDIA Study families made our session a success @BetaCellCRE Thanks to all who attended

Genetic risk stratification could improve the efficiency of a future national screening program for #type1diabetes @DrKirstieBell

Here with @DrKirstieBell at #adc2025 overviewing some findings from the national #type1diabetes screening pilot.

Congratulations to Dr Sybil McAuley on her mid career researcher award at #adc2025 around #type1diabetes and therapeutic strategies

We need a coordinated strategy in Australia to rethink regulatory approval and accelerate access in #type1diabetes states Dr Jennifer Snaith ⁦@GarvanInstitute⁩

Look out for the upcoming TIRTLE2 Trial looking like it could bring about some promising results for those with #type1diabetes

The #t1d tempest by Dr Jennifer Snaith and colleagues

Amazing outcomes from #type1diabetes research by Prof Toby Coates and colleagues 👏

Fantastic outcomes for this person with #type1diabetes who received gene modified allogenic islets hypo-immune platform (HIP) islets

“The best way to get time in range for those with #type1diabetes is a pancreas transplant” says Prof Toby Coates. If only the immunosuppression wasn’t such a factor and we didn’t have to use someone else’s #pancreas 😢